Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of GSK2202083A Vaccine in Healthy Infants
NCT01090453Phase 2Completed
- Sponsor
- GSK
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of GSK2202083A in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started May 2010; status: completed.
02
Drugs
GSK2202083A
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT01090453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090453.